NOI.pdf
PDF 114 KB Posted
- Solicitation number
- FDANOI124038
About this file
This document is a Presolicitation Notice indicating the U.S. Food and Drug Administration's (FDA) intent to award a sole-source contract to Eurofins Panlabs, Inc. for in vitro safety data screening on chemical compounds of concern.
The FDA requires this data to predict the safety of chemicals, which is critical for carrying out its regulatory mission to protect public health. The anticipated contract period is a base plus two option years. The applicable NAICS code is 541715, Research and Development in the Physical, Engineering, and Life Sciences. The government intends to solicit and negotiate directly with Eurofins Panlabs, Inc. and will not issue a formal solicitation. Any interested parties who believe they can meet the requirement must submit a written statement of capabilities within 11 calendar days. Responses should be emailed to Telisha Wilson at the FDA by May 27, 2024 at 10:00 AM EST. No phone calls or faxes will be accepted.
View the file
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
PRESOLICITATION NOTICE: INTENT TO AWARD A SOLE-SOURCE CONTRACT
INTENDED SOURCE: Eurofins Panlabs, Inc.–6 Research Park Drive, Saint Charles, MO63304-
ANTICIPATED PERIOD of PERFORMANCE: Base plus 2 option years
DESCRIPTION OF REQUIREMENT:
Pursuant to the authority of 41 USC 3304(a)(1), as implemented by Federal Acquisition Regulation (FAR) Subpart 6.302-1, the U.S. Food and Drug Administration (FDA), Office of Acquisitions and Grant Services (OAGS) intends to award a sole source contract to Eurofins Panlabs, Inc.. FDA has a need To obtain in vitro safety data on chemical compounds of concern to CFSAN screened against a panel of biological targets. This data will allow CFSAN/OARSA/DOT to predict the safety of these chemicals, which is vital for carrying out the regulatory mission of CFSAN to protect public health.
The applicable North American Industry Classification System (NAICS) code for this acquisition is 541715, Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) 11.
The Government intends to solicit and negotiate directly with Eurofins Panlabs, Inc and no solicitation will be issued. This notice of intent is not a request for competitive proposals or quotations; however, if any interested party believes they can meet the above requirement, it may submit a statement of capabilities. The statement of capabilities must be submitted in writing and must contain material in sufficient detail to allow the government to determine if the party can perform the requirement. A determination by the Government not to compete this proposed requirement based on responses to this notice is solely within the discretion of the Government.
All interested parties must express their interest and capabilities in writing via email to Telisha.Wilson@fda.hhs.gov within eleven (11) calendar days after the date of publication of this notice. No faxed documents will be accepted. If no responsive statements are received within eleven (11) calendar days, an award will subsequently be made to Eurofins Panlabs, Inc.
This is a Federal contract opportunity; FDA-NOI-124038 for services at Food and Drug Administration Office of Acquisitions and Grants Services - Rockville, MD.
Response Date: May 27, 2024 by 10:00AM EST. Please email responses to Telisha Wilson at Telisha.wilson@fda.hhs.gov. No phone calls or faxes will be accepted.
mailto:Telisha.wilson@fda.hhs.gov
File details come from the government source that posted it. Updated .